X0202 SCHEDULE 13G/A 0001085146-25-005954 0001404574 XXXXXXXX LIVE 1 Common Stock, $0.00001 par value per share 03/31/2026 0001572616 FRACTYL HEALTH, INC. 35168W103 3 VAN DE GRAAFF DRIVE SUITE 200 BURLINGTON MA 01803 Rule 13d-1(c) 683 Capital Management, LLC DE 0 7679615 0 7679615 7679615 N 4.81 IA 683 Capital Partners, LP DE 0 7679615 0 7679615 7679615 N 4.81 PN Ari Zweiman X1 0 7679615 0 7679615 7679615 N 4.81 IN FRACTYL HEALTH, INC. 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MASSACHUSETTS 01803 683 Capital Management, LLC 683 Capital Partners, LP Ari Zweiman Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." The principal business address for each of the Reporting Persons is 1700 Broadway, Suite 4200, New York, New York 10019. 683 Capital Management, LLC - DELAWARE 683 Capital Partners, LP - DELAWARE Ari Zweiman - UNITED STATES Y As of March 31, 2026, 683 Capital Partners, LP beneficially owned (i) 6,727,235 shares of Common Stock and (ii) warrants to purchase 952,380 shares of Common Stock which are currently exercisable. 683 Capital Management, LLC, as the investment manager of 683 Capital Partners, LP, may be deemed to have beneficially owned the (i) 6,727,235 shares of Common Stock and (ii) warrants to purchase 952,380 shares of Common Stock which are currently exercisable beneficially owned by 683 Capital Partners, LP. Ari Zweiman, as the Managing Member of 683 Capital Management, LLC, may be deemed to have beneficially owned (i) 6,727,235 shares of Common Stock and (ii) warrants to purchase 952,380 shares of Common Stock which are currently exercisable beneficially owned by 683 Capital Management, LLC. The following percentage is based on 158,648,963 shares of Common Stock outstanding per the Issuer's Form 10-K filed on March 24, 2026 plus 952,380 shares of Common Stock issuable upon exercise of currently exercisable warrants held by the Reporting Persons. As of May 15, 2026, the Reporting Persons may be deemed to have beneficially owned 7,679,615 shares of Common Stock, constituting approximately 4.81% of the outstanding shares of Common Stock. 4.81 See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. N Y Y Y N See Exhibit A to Schedule 13G as filed on October 14, 2025. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. 683 Capital Management, LLC Ari Zweiman 05/15/2026 683 Capital Partners, LP Ari Zweiman 05/15/2026 Ari Zweiman Ari Zweiman 05/15/2026